All Lena Oevermann articles
-
NewsGermany marks first CRISPR therapy success
A 19-year-old with severe beta-thalassemia has become the first patient in Germany to receive an approved CRISPR-based therapy as part of routine medical care. Four months after treatment at Charité, he no longer requires regular blood transfusions, marking a major step in bringing gene editing from the laboratory into everyday clinical practice.